Telehealth Adoption Among Endocrinologists During The Covid-19 Pandemic.
Journal
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
ISSN: 1530-891X
Titre abrégé: Endocr Pract
Pays: United States
ID NLM: 9607439
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
24
04
2020
accepted:
27
06
2020
entrez:
20
1
2021
pubmed:
21
1
2021
medline:
23
1
2021
Statut:
ppublish
Résumé
Telehealth is a timely solution for delivering health care during the coronavirus disease 2019 (COVID-19) pandemic. The practice of endocrinology is suited to provide virtual care to patients with a variety of endocrine disorders. In this survey, we aimed to gauge the adoption of telehealth practices during the COVID-19 pandemic among endocrinologists in the United States (U.S.). This was a cross-sectional, online survey-based study. Members of the Facebook group "Endocrinologists" were invited to participate in the survey. Characteristics of respondents and their rates of adoption of telehealth were described and analyzed for statistically significant associations using the Pearson chi-square test. A total of 181 physicians responded to the survey. The majority of respondents were females (75%), younger than or equal to 40 years of age (51%), employed (72%) either by a private group/hospital or by an academic setting, worked in an urban area (88.4%), and were adult endocrinologists (93%). With the COVID-19 outbreak, more than two-fifths (44.2%) of participants switched to completely virtual visits, and an additional 44.2% switched to a majority of virtual visits, with some in-person visits in the outpatient setting. Additionally, there was a significantly higher adoption rate of telehealth among endocrinologists younger than or equal to 40 years of age (P = .02) and among those who practiced in northeastern, midwestern, and the western geographic regions of the U.S. (P = .04). The majority of the responding endocrinologists from the U.S. appeared to have swiftly adapted by using telehealth within a few weeks of COVID-19 being declared a national emergency. CMS = Centers for Medicare and Medicaid Services; COVID-19 = coronavirus disease 2019; PPE = personal protective equipment; U.S. = United States.
Identifiants
pubmed: 33471676
pii: S1530-891X(20)48176-5
doi: 10.4158/EP-2020-0237
pmc: PMC7837189
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
846-856Informations de copyright
© 2020 American Association of Clinical Endocrinologists. Published by Elsevier, Inc. All rights reserved.
Références
Telemed J E Health. 2015 May;21(5):321-54
pubmed: 25806910
Stud Health Technol Inform. 2004;105:112-20
pubmed: 15718600
N Engl J Med. 2020 Mar 5;382(10):929-936
pubmed: 32004427
J Diabetes Sci Technol. 2008 Jul;2(4):681-4
pubmed: 19885244
Telemed J E Health. 2014 Sep;20(9):769-800
pubmed: 24968105
Endocrinol Metab Clin North Am. 2016 Dec;45(4):895-904
pubmed: 27823610
J Diabetes Sci Technol. 2019 Jul;13(4):664-673
pubmed: 30453772
Telemed J E Health. 2015 Dec;21(12):953-79
pubmed: 26394022
Br J Gen Pract. 2019 Aug 29;69(686):e586-e594
pubmed: 31160368
Telemed J E Health. 2015 Feb;21(2):81-5
pubmed: 25474190
Clin Cardiol. 2011 Jul;34(7):420-5
pubmed: 21618252
J Am Med Inform Assoc. 2020 Jun 1;27(6):957-962
pubmed: 32311034
Int J Med Inform. 2015 Sep;84(9):601-16
pubmed: 26072326
JAMA. 2013 Jul 3;310(1):46-56
pubmed: 23821088
J Telemed Telecare. 2015 Sep;21(6):323-30
pubmed: 25995331